Beijing Baishihekang Pharmaceutical Technology key facts
as of Oct 2026- Developer of a pharmaceutical technology designed to advance medical research and development.
- Beijing Baishihekang Pharmaceutical Technology is valued at approximately $138.0M as of Oct 2026 (last reported valuation).
- It has raised $6.8M; the latest was Early Stage VC ($6.8M) in Apr 2025.
- Notable investors include Beijing Zhongguancun Venture Capital Development, Beijing Bewinner Communications Company.
- Status: Privately Held (backing).
Beijing Baishihekang Pharmaceutical Technology's last reported valuation, Apr 2025. Nothing priced has surfaced since.
- ·Watch Beijing Baishihekang Pharmaceutical Technology: the Monday email on marks, rounds and moves
Beijing Baishihekang Pharmaceutical Technology funding rounds
No funding rounds for Beijing Baishihekang Pharmaceutical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Beijing Baishihekang Pharmaceutical Technology
2Beijing Baishihekang Pharmaceutical Technology valuation
Beijing Baishihekang Pharmaceutical Technology's last reported valuation was $138 million in Apr 2025. No priced round, secondary trade or fund mark has surfaced since.
Beijing Baishihekang Pharmaceutical Technology investors
2 investors are on record for Beijing Baishihekang Pharmaceutical Technology, including Beijing Zhongguancun Venture Capital Development and Beijing Bewinner Communications Company.
About Beijing Baishihekang Pharmaceutical Technology
Developer of a pharmaceutical technology designed to advance medical research and development. The company offers innovative biobased materials and comprehensive technical services, enabling healthcare professionals to enhance patient care and treatment outcomes.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.